WA-KYMETA
8.6.2021 15:02:04 CEST | Business Wire | Press release
Kymeta (kymetacorp.com ), the communications company making mobile global, announced today a strategic technology partnership with Comtech EF Data Corp. (comtechefdata.com ), a leading provider of satellite communication equipment. The agreement enables Kymeta to broaden its network of offerings for the Kymeta™ u8 terminal through interoperability with Comtech’s SLM-5650B modem.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210608005043/en/
The pairing of the u8 antenna and Comtech modem using the Open Antenna to Modem Interface Protocol (OpenAMIP), an industry-wide open-source standard for antenna-router integration, allows for seamless integration and automatic operation through the use of both Low Density Parity Check (“LDPC”) waveforms and STANAG 4486 Edition 3, Annex E (EBEM) waveforms.
The Comtech SLM-5650B is a U.S. Army Forces Strategic Command (ARSTRAT) Wideband Global SATCOM certified modem for critical commercial backhaul, as well as government and military applications. It is fully compliant with MIL-STD-188-165A/B, complies with and supports FIPS 140-2 certified encryption.
Kymeta u8 terminals, antennas, and ODUs are easy to set up and acquire service within minutes of installation. The u8 is also available in a transportable configuration called the u8 GO, which is ideal for rapid deployments. The u8 GO enables safe transport with a hardened case for protection and provides a built-in car mount to support easy communications on the pause (COTP) and on the move (COTM).
“The integration of the u8 antenna with the Comtech modem allows users to upgrade to a SATCOM-on-the-move (SOTM) capability while utilizing existing modem and hub architecture,” said Neville Meijers, Kymeta Chief Strategy and Marketing Officer. “The ability to leverage existing network hardware while adding the SOTM capability will rapidly enhance unit capabilities. The low SWaP-C2 of the u8 terminal also makes it a perfect choice for upgrading legacy COTM terminals.”
“Comtech is very excited to expand our solution set and capabilities offered to our government and military user base,” said Fred Kornberg, Chairman of the Board and Chief Executive Officer of Comtech Telecommunications Corp. “The engineering, development, and testing of the mobility protocols between our widely fielded SLM-5650B satellite modem and Kymeta’s state-of-the-art u8 antenna expands the range of missions we can support and further demonstrates the flexibility and long-term developmental support our government and military users expect from our products.”
Kymeta’s next-generation solutions are built for mobility and designed to meet the needs of global defense agencies, government, public safety, and commercial customers. Kymeta’s products and services have been field deployed for over three years and received an overwhelmingly positive response from the industry. Kymeta’s new products and services offer a breakthrough in performance, ease of use, and affordability, and Kymeta anticipates that these solutions will further enhance its position in both commercial and government markets, further increasing its lead over competitive offerings.
This strategic technology partnership with Comtech follows a series of recently announced relationships to further expand Kymeta solutions and trainings for government and defense agencies and its Global TRANSEC Secure Network , which is available coverage in the U.S., Middle East, and Europe. Visit www.kymetacorp.com to learn more.
About Kymeta
Kymeta is unlocking the potential of broadband satellite connectivity, combined with cellular networks, to satisfy the overwhelming demand for comms on the move and making mobile global. Lepton Global Solutions, a Kymeta company, hosts the company’s satellite connectivity solutions and offers unique, complete, and turnkey bundled solutions to the market based on best-in-class technologies and tailored customer-centric services that meet and exceed customer mission requirements. These solutions in tandem with the company’s flat-panel satellite antenna, the first of its kind, and Kymeta Connect™ services provide revolutionary mobile connectivity on satellite and hybrid satellite-cellular networks to customers around the world. Backed by U.S. and international patents and licenses, the Kymeta terminal addresses the need for lightweight, slim, and high-throughput communication systems that do not require mechanical components to steer toward a satellite. Kymeta makes connecting easy – for any vehicle, vessel, or fixed platform.
Kymeta is a privately held company based in Redmond, Washington.
For more information, visit kymetacorp.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210608005043/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bial Announces Completion of Phase 2b ACTIVATE Study with BIA 28-6156 in GBA1-Associated Parkinson’s26.5.2026 08:00:00 CEST | Press release
Study Topline results will be released around the end of Q2 2026 BIA 28-6156 is being developed as a potential first-in-class disease-modifying therapy in GBA-PD Bial was present at the GBA1 conference and is currently attending the World Parkinson Congress Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced the completion of the treatment period in its Phase 2b ACTIVATE study of BIA 28-6156 (pariceract) in patients with Parkinson’s disease (PD) who have a pathogenic mutation in the glucocerebrosidase 1 (GBA1) gene (GBA-PD). Upon completion of the 78-week double-blind treatment period and all scheduled safety follow-ups, data cleaning and analysis are currently ongoing. Topline results will be released around the end of Q2. A status report on the ACTIVATE study was presented in an oral presentation at the 3rd International GBA1 Meeting 2026. The team is currently attending the 7th World Parkinson Congress, taking place in Pho
Oticon Medical Introduces Ponto™ Instant, Expanding Non-Surgical Choice with Instant HearBand and Instant SoundConnector26.5.2026 07:00:00 CEST | Press release
Oticon Medical today announces its new non-surgical portfolio, Ponto Instant, designed to broaden access to bone conduction hearing and offer more choice for users and hearing care professionals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260525771593/en/ Left: Instant HearBand, a discreet behind-the-head wearable solution that offers an alternative to Softband 5. Right: Instant SoundConnector, a small accessory fitted to a cap or other headwear, providing another non-surgical way to wear a Ponto sound processor. The Ponto Instant portfolio includes Softband 5, Oticon Medical’s established and trusted non-surgical solution, and now expands with the launch of Instant HearBand and Instant SoundConnector, further strengthening its wearable offering for children and adults who prefer a non-surgical solution. Instant HearBand: a discreet new wearable alternative As part of the new portfolio, Instant HearBand is introduced as
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom